AnaBio Technologies addresses the needs of many food, feed and pharmaceutical enterprises to follow the demand for improved “healthier” versions of their products. At AnaBio, we are devoted to developing capsules, beads, gels and other solution technologies to support our customer’s most difficult delivery and dosing challenges in a broad range of applications.
AnaBio is currently working with companies in three target markets:
- Human Health and Functional Food;
- Animal Health and Nutrition and
- Therapeutic Drugs and medicinal substances.
It is the vision of AnaBio to continue working within these markets to in order to extend the current portfolio of AnaBio patent licensees.
From a commercial perspective, AnaBio’s patented technologies can help:
- reduce costs;
- improve production yield and shelf-life;
- enhance product functionality and
- provide industry with competitive advantage.
AnaBio has generated “platform” technologies that with a proven track-record for broad spectrum market introduction of commercially viable, value-added encapsulation systems. This allows AnaBio clients to penetrate values-added niche markets in an economical cost – efficient manner.
In reality, AnaBio’s Unique Selling Point (USP) involves enhancing existing products or developing new products for food, feed and pharmaceutical industries with proven claims for improved health and wellbeing for their target market.
Please review this YouTube video for further explanation of AnaBio’s USP